Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

REGISTER for free or LOG IN to view this content

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Policy & Practice

Prevention

CAD Pharma

Clinical Pharma

Coronary

Stroke

Factoid

Up Next

Presentation

Prehospital ECG by Emergency Medical Personnel: Effects on Scene and Transport Times for Chest Pain and STEMI Patients

Presenter: M. Patel

July 25, 2012

More slides +

Presentation GI2 2012

What is in the Pipeline for Coronary Artery Disease?

Presenter: Martin B. Leon

April 13, 2012

Presentation

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presenter: S. Cassese

August 06, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.